(Q34255166)

English

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

scientific article published on July 27, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

14

object named as

Hyo Seop Ahn

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Seok Jin Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jong Wook Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chul Won Jung

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chang Ki Min

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Bin Cho

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ho Jin Shin

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joo Seop Chung

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hawk Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Won Sik Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Young Don Joo

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Deok-Hwan Yang

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hoon Kook

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hyoung Jin Kang

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sung-Soo Yoon

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sang Kyun Sohn

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yoo Hong Min

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Woo-Sung Min

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hee-Sook Park

19

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jong Ho Won

20

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20663943

11 June 2024

publication date

27 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

full work available at URL

https://haematologica.org/article/download/5791/27682

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

http://www.haematologica.org/journal/2010/951935.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

http://www.haematologica.org/journal/2010/11/1935.html

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20663943/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20663943/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://europepmc.org/articles/PMC2966917

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://europepmc.org/articles/PMC2966917?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

https://doi.org/10.3324/haematol.2010.026104

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20663943

11 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1935-1942

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Quality of life after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Hematopoietic stem-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Chronic graft-versus-host disease: clinical manifestation and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

How I treat chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

How large should a phase II trial of a new drug be?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

6 July 2018

Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966917

28 October 2018

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab as salvage therapy for refractory chronic GVHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/20663943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.026104

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34255166&oldid=2176627260"